Portal
Order

MI Cancer Seek® is now available for clinical ordering. Learn more.

Where Molecular Science
Meets Artificial Intelligence

For Patients

Personalized Treatment

Understand cancer at the molecular level to inform treatment options personalized for you.

For Physicians

Precision Medicine

Reveal a molecular blueprint across DNA, RNA and proteins to guide individualized treatment decisions.

For Biopharma

Precision Partnering

Inform and empower your precision oncology programs to accelerate drug discovery, translational medicine, clinical development and commercialization.

Improving the Human Condition

Every human has a unique molecular code, one made up of a universe of biological networks that provide the source of life. And the root cause for nearly every type of disease is that an error has occurred somewhere in that code. At Caris Life Sciences, we’ve developed solutions and created innovative tools to analyze this biological web. These innovations hold the key to better detect, categorize, treat and inform, unraveling the molecular complexity of disease and helping improve patient outcomes.

Caris was founded in 2008 with a simple but powerful purpose – to help improve the lives of as many people as possible. With transformative technologies informed by massive amounts of data, we are trailblazing the path to precision medicine by providing physicians and patients with the highest quality information about disease.

The Caris Continuum of Care

With products and services that support the full care continuum, we’re here for you every step of the way on your journey for the best possible outcome.

Disease Detection

Catch disease early when it can be more easily treated.

Learn More

Therapy Selection

Inform therapy selection with molecular information about your specific cancer.

Tissue-Based Profiling
Blood-Based Profiling

Treatment Monitoring

Monitor how your cancer is responding to treatment.

Learn More

“Caris was built for one reason — to improve the human condition. Through tireless efforts, breakthrough molecular science, and a passionate commitment to quality, we remain steadfastly focused on the most important part of our work — the patient.”

-David Dean Halbert, DSc (h.c.), Chairman, Founder and CEO

Driving Molecular Science Innovation

849,000+

Cases

6.5+ Million

Tests

38+ Billion

Molecular Markers Measured

With the molecular profiling done by Caris, my doctor was able to pinpoint treatment that would work best for my individual situation, which thankfully proved successful. Molecular profiling is so critical – information is such power.”

Patient, Diane Davis
Ovarian Cancer Survivor

View All Patient Testimonials

Diane Davis, Ovarian Cancer Survivor

Products At-a-Glance

Caris Assure

Whole Exome and Whole Transcriptome Sequencing from blood. This revolutionary, pan-cancer assay utilizes a novel circulating Nucleic Acid Sequencing (cNAS) approach. With deep molecular insights from a minimally invasive blood sample, Caris Assure® delivers uncompromising reliability and performance to inform personalized treatment decisions to help improve patient outcomes.

Learn More